查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1546204

质子治疗的全球市场

Proton Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球质子治疗市场预计将达到 15 亿美元

2023年全球质子治疗市场估计为6.146亿美元，预计到2030年将达到15亿美元，2023年至2030年复合年增长率为13.5%。加速器是本报告分析的细分市场之一，预计复合年增长率为 13.7%，到分析期结束时将达到 8.436 亿美元。分析期间，光束传输系统领域的复合年增长率预计为 14.2%。

美国市场预估为1.656亿美元，中国预期复合年增长率为12.5%

预计 2023 年美国质子治疗市场规模将达到 1.656 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达2.238亿美元，推动2023-2030年分析期间复合年增长率为12.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 12.0% 和 11.2%。在欧洲，德国的复合年增长率预计约为 9.5%。

全球质子治疗市场 - 主要趋势和驱动因素总结

不断增长的质子治疗市场以高精度标靶化癌症

质子治疗是最先进的放射线治疗，透过提供高度精确和有效的肿瘤标靶选择，正在改变癌症治疗的面貌。与会损害周围健康组织的传统 X 射线辐射不同，质子疗法使用带电粒子（质子）将其最大能量直接传递到肿瘤部位，从而最大限度地减少对邻近健康组织的损害。这种精确性使得质子疗法在治疗大脑、脊椎和眼睛等关键结构附近的肿瘤时特别有用，而传统的放射治疗在这些部位可能会产生严重的副作用。随着人们越来越重视癌症治疗的精准性和个人化，质子治疗被认为是许多患者的更好选择，尤其是儿童和病情复杂的患者。

科技进步如何增强质子治疗？

技术进步在扩大和改进质子治疗方面发挥着至关重要的作用。影像技术的创新，例如基于 MRI 和 CT 的治疗计划，显着提高了质子束照射的准确性，使临床医生能够更好地可视化肿瘤并精确地计划治疗。笔射束扫描 (PBS) 技术的发展进一步提高了质子治疗的精确度，能够提供与肿瘤精确形状相符的高度聚焦束，从而减少对周围健康组织的剂量。此外，加速器技术的进步减少了治疗设施的规模和成本，使质子治疗更容易实现。这些技术进步使质子治疗成为世界各地癌症治疗中心更可行、更有吸引力的选择。

质子束治疗的扩展应用有哪些？

随着临床证据支持质子束疗法治疗多种癌症的有效性，质子束疗法的应用正在扩大。质子疗法传统上用于治疗儿童癌症和关键结构附近的肿瘤，但现在它被用于乳腺癌、肺癌和胃肠道癌症，在这些癌症中，尽量减少对周围组织的辐射照射非常重要。癌症。质子束疗法有可能减少长期副作用并提高癌症倖存者的生活质量，使其可用于头部和颈部，因为唾液腺和声带等重要器官可能受到严重损伤。此外，正在进行的研究正在调查如何将其与免疫疗法和化疗等其他治疗方法结合使用，以提高整体治疗效果。这些扩展的应用正在扩大质子束治疗在癌症治疗中的范围。

市场成长的主要驱动力是什么？

质子治疗市场的成长受到多种因素的推动。全球癌症发生率的增加是一个主要驱动因素，因为对先进、准确和有效的治疗方案的需求不断增加。成像、光束传输和加速器设计方面的技术进步极大地提高了质子治疗的可及性和有效性，使其成为治疗中心更有吸引力的选择。质子疗法治疗的癌症范围不断扩大，以及越来越多的临床证据支持其益处，也推动了质子疗法的采用。此外，对个人化医疗和精准医疗的日益关注正在推动质子治疗的使用，特别是在传统放射治疗可能导致严重副作用的情况下。随着全球医疗保健界继续优先考虑以患者为中心的护理，对质子治疗的需求预计将显着增长。

调查企业范例（共43例）

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP14268

Global Proton Therapy Market to Reach US$1.5 Billion by 2030

The global market for Proton Therapy estimated at US$614.6 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. Growth in the Beam Delivery Systems segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$165.6 Million While China is Forecast to Grow at 12.5% CAGR

The Proton Therapy market in the U.S. is estimated at US$165.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$223.8 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Proton Therapy Market - Key Trends and Drivers Summarized

Targeting Cancer with Precision: The Growing Market for Proton Therapy

Proton therapy is a cutting-edge form of radiation therapy that is transforming the way cancer is treated, offering a highly precise and effective option for targeting tumors. Unlike conventional X-ray radiation, which can damage surrounding healthy tissues, proton therapy uses charged particles (protons) that deliver their maximum energy directly to the tumor site, minimizing collateral damage to adjacent healthy cells. This precision makes proton therapy particularly valuable in treating tumors located near critical structures, such as the brain, spine, and eyes, where conventional radiation could cause significant side effects. As cancer treatment becomes increasingly focused on precision and personalized care, proton therapy is gaining recognition as a superior option for many patients, especially children and those with complex cases.

How Are Technological Advancements Enhancing Proton Therapy?

Technological advancements have played a pivotal role in the expansion and improvement of proton therapy. Innovations in imaging technologies, such as MRI and CT-based planning, have significantly enhanced the accuracy of proton beam delivery, allowing clinicians to better visualize tumors and plan treatments with pinpoint precision. The development of pencil beam scanning (PBS) technology has further improved the precision of proton therapy by enabling the delivery of highly focused beams that can conform to the exact shape of the tumor, reducing the dose to surrounding healthy tissues. Additionally, advancements in accelerator technology have made proton therapy more accessible by reducing the size and cost of treatment facilities. These technological improvements are making proton therapy a more viable and attractive option for cancer treatment centers around the world.

What Are the Expanding Applications of Proton Therapy?

The applications of proton therapy are expanding as more clinical evidence supports its efficacy in treating a wide range of cancers. While traditionally used for pediatric cancers and tumors near critical structures, proton therapy is now being explored for use in treating breast, lung, and gastrointestinal cancers, where minimizing radiation exposure to surrounding tissues is crucial. The potential for proton therapy to reduce long-term side effects and improve the quality of life for cancer survivors is also driving its adoption in the treatment of head and neck cancers, where traditional radiation can cause significant damage to critical organs such as the salivary glands and vocal cords. Additionally, ongoing research is investigating the use of proton therapy in combination with other treatments, such as immunotherapy and chemotherapy, to enhance overall treatment outcomes. These expanding applications are broadening the scope of proton therapy in cancer care.

What Are the Key Growth Drivers in the Market?

The growth in the proton therapy market is driven by several factors. The increasing incidence of cancer worldwide is a major driver, as the demand for advanced, precise, and effective treatment options continues to rise. Technological advancements in imaging, beam delivery, and accelerator design have significantly improved the accessibility and efficacy of proton therapy, making it a more attractive option for treatment centers. The expanding range of cancers that can be treated with proton therapy, coupled with the growing body of clinical evidence supporting its benefits, is also driving adoption. Additionally, the increasing focus on personalized and precision medicine is encouraging the use of proton therapy, particularly in cases where traditional radiation could cause significant side effects. As the global healthcare community continues to prioritize patient-centered care, the demand for proton therapy is expected to grow substantially.

Select Competitors (Total 43 Featured) -

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Proton Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Propels Market Growth
    • Increasing Adoption of Advanced Radiation Therapies Expands Addressable Market Opportunity
    • Technological Advancements in Proton Therapy Systems Strengthen Market Position
    • Growing Focus on Precision Medicine Drives Adoption of Proton Therapy
    • Surge in Demand for Non-Invasive Cancer Treatments Generates New Opportunities
    • Development of Compact and Affordable Proton Therapy Systems Sustains Market Growth
    • Expanding Applications in Pediatric Oncology Throws Spotlight on Market Potential
    • Growth in Global Healthcare Infrastructure Spurs Demand for Proton Therapy
    • Rising Awareness of Proton Therapy's Advantages Over Traditional Radiation Propels Market Expansion
    • Surge in Demand from Emerging Markets Expands Market Horizons
    • Innovations in Image-Guided Proton Therapy Generate New Market Opportunities
    • Increasing Reimbursement Support for Proton Therapy Treatments Accelerates Market Growth
    • Rising Number of Proton Therapy Centers Worldwide Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Proton Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Accelerators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Beam Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Beam Transport Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CNS Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Head & Neck Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Proton Therapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION